Tag: Generic Medications
-
Lenacapavir Agreement: A Breakthrough in HIV Prevention
Introduction to Lenacapavir In a groundbreaking development for global health, a new injectable HIV prevention tool, lenacapavir, is set to be available at an astonishingly low price of just US$40 per year in 120 low- and middle-income countries (LMICs). This significant milestone comes as part of a landmark agreement announced on September 24, 2025, involving…
-
Zentiva’s Major Ownership Shift: Impact on Generic Medications in Romania
Zentiva’s Ownership Change: A New Era for Romania’s Generics Zentiva, the largest producer of generic medications in Romania, is set for a significant ownership change as it prepares to be acquired by the American private equity firm GTCR. This transaction, valued at a staggering 4.1 billion euros, marks a pivotal moment in the Romanian pharmaceutical…